Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial

• Laurène Fenwarth,
• Nicolas Duployez,
• Alice Marceau-Renaut,
• Wadih Abou Chahla,
• Stéphane Ducassou,
• Virginie Gandemer,
• Marlène Pasquet,
• Thierry Leblanc,
• Pascale Schneider,
• Carine Domenech,
• Paul Saultier,
• Guy Leverger,
• Hélène Lapillonne,
• Claude Preudhomme,
• Arnaud Petit

Affiliations

Laurène Fenwarth

Laboratory of Hematology, CHU Lille, INSERM UMR-S 1277, Lille, France;

Nicolas Duployez

Laboratory of Hematology, CHU Lille, INSERM UMR-S 1277, Lille, France;

Alice Marceau-Renaut

Laboratory of Hematology, CHU Lille, INSERM UMR-S 1277, Lille, France;

Wadih Abou Chahla

Pediatric Hematology Department, CHU Lille, Lille, France;

Stéphane Ducassou

Pediatric Hematology and Oncology Department, CHU Bordeaux, France;

Virginie Gandemer

Pediatric Hematology and Oncology Department, CHU Rennes, France;

Marlène Pasquet

Pediatric Hematology and Immunology Department, CHU Toulouse, France;

Thierry Leblanc

Pediatric Hematology Department, AP-HP Robert Debré Hospital, Paris, France;

Pascale Schneider

Pediatric Hematology Department, CHU Rouen, France;

Carine Domenech

Institute of Hematology and Pediatric Oncology, Lyon 1 University, Hospices Civils de Lyon, France;

Paul Saultier

Pediatric,Hematology,Oncology, Timone Enfants Hospital,Aix-Marseille University, Marseille, France;

Guy Leverger

Dept. Pediatric,Hematology,Oncology, Armand Trousseau Hospital, Sorbonne University, Paris, France;

Hélène Lapillonne

Laboratory of Hematology, Armand Trousseau Hospital, Sorbonne University, Paris, France;

Claude Preudhomme

Laboratory of Hematology, CHU Lille, INSERM UMR-S 1277 - 9020 CNRS, Lille, France

Arnaud Petit

Dept. Pediatric,Hematology,Oncology, Armand Trousseau Hospital, Sorbonne University, Paris, France;